Abstract

Plasmodium species are frequently host-specific, but little is currently known about the molecular factors restricting host switching. This is particularly relevant for P. falciparum, the only known human-infective species of the Laverania sub-genus, all other members of which infect African apes. Here we show that all tested P. falciparum isolates contain an inactivating mutation in an erythrocyte invasion associated gene, PfEBA165, the homologues of which are intact in all ape-infective Laverania species. Recombinant EBA165 proteins only bind ape, not human, erythrocytes, and this specificity is due to differences in erythrocyte surface sialic acids. Correction of PfEBA165 inactivating mutations by genome editing yields viable parasites, but is associated with down regulation of both PfEBA165 and an adjacent invasion ligand, which suggests that PfEBA165 expression is incompatible with parasite growth in human erythrocytes. Pseudogenization of PfEBA165 may represent a key step in the emergence and evolution of P. falciparum.

Details

Title
Adaptation of Plasmodium falciparum to humans involved the loss of an ape-specific erythrocyte invasion ligand
Author
Proto, William R 1   VIAFID ORCID Logo  ; Siegel, Sasha V 1   VIAFID ORCID Logo  ; Dankwa, Selasi 2   VIAFID ORCID Logo  ; Liu, Weimin 3 ; Kemp, Alison 1 ; Marsden, Sarah 1 ; Zenonos, Zenon A 1 ; Unwin, Steve 4 ; Sharp, Paul M 5   VIAFID ORCID Logo  ; Wright, Gavin J 1 ; Hahn, Beatrice H 3   VIAFID ORCID Logo  ; Duraisingh, Manoj T 2 ; Rayner, Julian C 6   VIAFID ORCID Logo 

 Malaria Programme, Wellcome Sanger Institute, Wellcome Genome Campus, Cambridge, UK 
 Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, MA, USA 
 Departments of Medicine and Microbiology, University of Pennsylvania, Philadelphia, PA, USA; Department of Microbiology, University of Pennsylvania, Philadelphia, PA, USA 
 Chester Zoo, Chester, UK; School of Biosciences, University of Birmingham, Edgbaston, UK 
 Institute of Evolutionary Biology, University of Edinburgh, Edinburgh, UK 
 Malaria Programme, Wellcome Sanger Institute, Wellcome Genome Campus, Cambridge, UK; Cambridge Institute for Medical Research, University of Cambridge, Cambridge, UK 
Pages
1-12
Publication year
2019
Publication date
Oct 2019
Publisher
Nature Publishing Group
e-ISSN
20411723
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2300955280
Copyright
© 2019. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.